Search by Drug Name or NDC

    NDC 73289-0060-02 Formoterol Fumarate 0.02 mg/2mL Details

    Formoterol Fumarate 0.02 mg/2mL

    Formoterol Fumarate is a RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aucta Pharmaceuticals, Inc. The primary component is FORMOTEROL FUMARATE.

    Product Information

    NDC 73289-0060
    Product ID 73289-0060_f1da053e-9d8f-68ee-e053-2995a90a9882
    Associated GPIs
    GCN Sequence Number 063016
    GCN Sequence Number Description formoterol fumarate VIAL-NEB 20 MCG/2ML INHALATION
    HIC3 B6Y
    HIC3 Description BETA-ADRENERGIC AGENTS, ORALLY INHALED,LONG ACTING
    GCN 98776
    HICL Sequence Number 010747
    HICL Sequence Number Description FORMOTEROL FUMARATE
    Brand/Generic Generic
    Proprietary Name Formoterol Fumarate
    Proprietary Name Suffix n/a
    Non-Proprietary Name formoterol fumarate dihydrate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 0.02
    Active Ingredient Units mg/2mL
    Substance Name FORMOTEROL FUMARATE
    Labeler Name Aucta Pharmaceuticals, Inc
    Pharmaceutical Class Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216486
    Listing Certified Through 2024-12-31

    Package

    NDC 73289-0060-02 (73289006002)

    NDC Package Code 73289-0060-2
    Billing NDC 73289006002
    Package 60 POUCH in 1 CARTON (73289-0060-2) / 2 mL in 1 POUCH (73289-0060-3)
    Marketing Start Date 2022-12-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 5.04483
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description FORMOTEROL 20 MCG/2 ML NEB VL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis